Results 11 to 20 of about 23,143 (229)
Vasopressin receptor antagonists [PDF]
The first non-peptide vasopressin receptor antagonist (VRA) was recently approved by the United States Food and Drug Administration, and several others are now in late stages of clinical development. Phase 3 trials indicate that these agents predictably reduce urine osmolality, increase electrolyte-free water excretion, and raise serum sodium ...
Arthur Greenberg, Joseph G. Verbalis
openaire +3 more sources
Phosphorylation of the V2 Vasopressin Receptor [PDF]
The V2 vasopressin receptor undergoes ligand-induced sequestration and desensitization (Birnbaumer, M., Antaramian, A., Themmen, A. P. N., and Gilbert, S. (1992) J. Biol. Chem. 267, 11783-11788). The V2 receptor expressed in transfected cells labeled with [32P] orthophosphate was phosphorylated following the addition of 100 nM arginine vasopressin (AVP)
INNAMORATI, Giulio+3 more
openaire +4 more sources
Vasopressin and Vasopressin Receptor Antagonists [PDF]
Vasopressin, a neurohypophyseal peptide hormone, is the endogenous agonist at V1a, V1b, and V2 receptors. The most important physiological function of vasopressin is the maintenance of water homeostasis through interaction with V2 receptors in the kidney.
openaire +3 more sources
Vasopressin V2 receptor antagonists [PDF]
Hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and disorders of water retention such as congestive heart failure and cirrhosis is a common problem encountered in the care of the medical patient. Thus far, available treatment modalities for disorders of excess arginine vasopressin (AVP) secretion or action have ...
Joseph G. Verbalis, Lisa L. Wong
openaire +3 more sources
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder
Autism spectrum disorder (ASD) is rather common, presenting with prevalent early problems in social communication and accompanied by repetitive behavior.
Kristóf László+6 more
doaj +1 more source
Aquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Review
This is a literature review of the use of aquaretic in patients with acute decompensated heart failure (ADHF), including the physiologic function of vasopressin and its mechanism of action in heart failure patients, and aquaretic drugs with their ...
Norman Sukmadi, Kevin Surya, Arif Sejati
doaj +2 more sources
OBJECTIVE: To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. METHODS: We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure ...
Paulo Roberto B. Evora+4 more
doaj +1 more source
Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
Arginine vasopressin can bind to high-affinity vasopressin V1a receptors in human leukocytes. This study aims to investigate the effects of arginine vasopressin on migration and chemotaxis of neutrophils and oxygen free radical release by human ...
Wiedermann Franz J.+5 more
doaj +1 more source
Oxytocin modulates human chemosensory decoding of sex in a dose-dependent manner
There has been accumulating evidence of human social chemo-signaling, but the underlying mechanisms remain poorly understood. Considering the evolutionarily conserved roles of oxytocin and vasopressin in reproductive and social behaviors, we examined ...
Kepu Chen+3 more
doaj +1 more source
Vasopressin Receptor Expression in the Placenta [PDF]
The arginine vasopressin (AVP) type 1a receptor (V1a) is well known to mediate vasoconstriction. In pregnancy, blood flow in the placenta is crucial for sustaining normal growth and development of the fetus. This is the first AVP receptor study in the placenta and fetal membranes. The aim was to compare, quantitatively, the level of V1a gene expression
Irene Koukoulas+7 more
openaire +4 more sources